[1/2] Rob Olan (C), employee of the healthcare investment fund Deerfield Management, departs Federal Court in Manhattan in New York, U.S., May 24, 2017.
FollowNEW YORK, Aug 1 (Reuters) - A long-running federal insider trading case based on leaks about planned changes to Medicare reimbursement rates will likely end with no convictions, after the remaining defendants agreed to enter deferred prosecution agreements.
In the healthcare case, the Manhattan appeals court said the leaked CMS information did not support fraud and theft charges against Huber, Olan and Blaszczak, though prosecutors could retry them on one or two counts each.
In their deferred prosecution agreements, Huber and Olan acknowledged trading on and Blaszczak acknowledged passing advance information about a proposed CMS rule change.
The case is U.S. v. Blaszczak et al, U.S. District Court, Southern District of New York, No.
Persons:
Rob Olan, Lucas Jackson, Theodore Huber, Robert Olan, David Blaszczak, Prosecutors, Huber, Olan, George Washington, Chris Christie's, Christopher Worrall, Blaszczak, District Judge Lewis Kaplan, Blaszczak's, David Patton, Barry Berke, Dani James, Damian Williams, Jonathan Stempel, Conor Humphries, David Gregorio Our
Organizations:
Deerfield Management, REUTERS, Aetna Inc, Centers, Medicare, Services, Democratic, New, New Jersey Republican, District, Court, Southern District of, Thomson
Locations:
Manhattan, New York, U.S, Deerfield, New Jersey, Southern District, Southern District of New York